PresaMD

United States Founded: 2023 • Age: 3 yrs Acquired By Morris and Dickson
Virtual third-party logistics solutions for pharmaceutical manufacturers are provided.

About PresaMD

PresaMD is a Healthcare company based in United States founded in 2023, and was acquired by Morris and Dickson in April 2025. Virtual third-party logistics solutions for pharmaceutical manufacturers are provided. Its focus areas include Pharmaceutical Distributors, Diversified, HealthTech and Life Sciences Tech. Its legal entity is PresaMD, Inc.

Company details

Virtual third-party logistics solutions for pharmaceutical manufacturers were established by PresaMD in 2023, based in the United States. Services including order management, invoicing, collections, deductions management, financial reporting, contract and chargeback administration, and flash title distribution are offered. Partnerships with manufacturers in the pharmaceutical sector are maintained to optimize supply chain operations, minimize capital requirements, and enhance financial visibility. Cloud-based platforms and industry-specific data systems are utilized for these functions.

Key Metrics

Investors in PresaMD

PresaMD has secured backing from 1 investor. Prominent investors backing the company include Morris and Dickson.

All
InvestorDescriptionFounded YearDomainLocation
Distributes pharmaceuticals and healthcare products to health systems, pharmacies, and alternate care facilities.
1841morrisdickson.comShreveport, United States
Premium access

Investor details for PresaMD

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of PresaMD

2 dated milestones of PresaMD across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded PresaMD is founded.
  2. Exit Acquired by Morris and Dickson.

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as PresaMD (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PresaMD

PresaMD was founded in 2023.

PresaMD is headquartered in United States.

Virtual third-party logistics solutions for pharmaceutical manufacturers were established by PresaMD in 2023, based in the United States. Services including order management, invoicing, collections, deductions management, financial reporting, contract and chargeback administration, and flash title distribution are offered. Partnerships with manufacturers in the pharmaceutical sector are maintained to optimize supply chain operations, minimize capital requirements, and enhance financial visibility. Cloud-based platforms and industry-specific data systems are utilized for these functions.

PresaMD has 1 investor. Key investors include Morris and Dickson.

PresaMD operates through Presamd, Inc.

Yes. PresaMD was acquired by Morris and Dickson in April 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available